Extending the use of stiripentol to other epileptic syndromes: A case of PCDH19-related epilepsy

European Journal of Paediatric Neurology

Volumn 19, Issue 2, 2015, Pages 248-250

  Trivisano, Marina ^a,b   Specchio, Nicola ^a   Vigevano, Federico ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Antiepileptic drugs; Dravet syndrome; PCDH19 related epilepsy; Stiripentol

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; MIDAZOLAM; PHENOBARBITAL; RISPERIDONE; STIRIPENTOL; TOPIRAMATE; VALPROIC ACID; 1,3 DIOXOLANE DERIVATIVE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CADHERIN; PCDH19 PROTEIN, HUMAN;

ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CHILD; COGNITIVE DEFECT; DEVELOPMENT; DRUG SUBSTITUTION; EPILEPSY; FEMALE; FOCAL EPILEPSY; HUMAN; INTENSIVE CARE UNIT; LEFT HEMISPHERE; MENTAL DEVELOPMENT; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SOMNOLENCE; AUTISM; COGNITION DISORDERS; COMBINATION DRUG THERAPY; DRUG RESISTANT EPILEPSY; EPILEPSIES, MYOCLONIC; FEVER; GENETICS; INTELLECTUAL IMPAIRMENT; PATHOPHYSIOLOGY; PSYCHOLOGY; SYNDROME; TREATMENT OUTCOME;

AGE OF ONSET; ANTICONVULSANTS; AUTISTIC DISORDER; BENZODIAZEPINES; CADHERINS; CHILD; COGNITION DISORDERS; DIOXOLANES; DRUG RESISTANT EPILEPSY; DRUG THERAPY, COMBINATION; EPILEPSIES, MYOCLONIC; EPILEPSY; FEMALE; FEVER; HUMANS; INTELLECTUAL DISABILITY; SYNDROME; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84923133010     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2014.11.008     Document Type: Article

References (14)

1. J.L. Fisher The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator Neuropharm 56 2009 190 197
2. C. Chiron Stiripentol Neurotherapeutics 4 2008 123 125
3. C. Giraud, J.M. Treluyer, and E. Rey In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism Drug Metab Dispos 34 2006 608 611
4. J. Perez, C. Chiron, and C. Musial Stiripentol: efficacy and tolerability in children with epilepsy Epilepsia 40 1999 1618 1626
5. C. Chiron, M.C. Marchand, and A. Tran Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group Lancet 356 2000 1638 1642
6. E.C. Wirrell, L. Laux, D.N. Franz, and J. Sullivan Stiripentol in Dravet syndrome: results of a retrospective U.S. study Epilepsia 54 2013 1595 1604
7. C. Chiron, S. Tonnelier, and E. Rey Stiripentol in childhood partial epilepsy: a randomized placebo-controlled trial with enrichment and withdrawal design J Child Neurol 21 2006 496 502
8. D. Merdariu, D. Delanoe, and N. Mahfoufi Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam Brain Dev 35 2013 177 180
9. C. Marini, D. Mei, and L. Parmeggiani Protocadherin 19 mutations in girls with infantile onset epilepsy Neurology 75 2010 646 653
10. N. Specchio, C. Marini, and A. Terracciano Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations Epilepsia 52 2011 1251 1257
11. C. Depienne, D. Bouteiller, and B. Keren Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females PLoS Genet 5 2 2009 e1000381
12. C. Marini, F. Darra, and N. Specchio Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy Epilepsia 53 2012 2111 2119
13. J.R. Farwell, G.D. Anderson, and B.M. Kerr Stiripentol in atypical absence seizures in children: an open trial Epilepsia 34 1993 305 311
14. G. Coppola, P. Plouin, C. Chiron, O. Robain, and O. Dulac Migrating partial seizures in infancy: a malignant disorder with developmental arrest Epilepsia 36 1995 1017 1024